Fig. 1.
The intravitreous aflibercept vs vitrectomy with panretinal photocoagulation for vitreous haemorrhage from proliferative diabetic retinopathy randomised clinical trial by the DRCR Retina Network showed that there was no statistically significant difference in visual acuity at 24 weeks following initial treatment with aflibercept compared to vitrectomy with panretinal photocoagulation. PRP panretinal photocoagulation, DRCR Diabetic Retinopathy Clinical Research, ETDRS Early Treatment Diabetic Retinopathy Study, VA visual acuity.
Reference to original study: Antoszyk AN, Glassman AR, Beaulieu WT, Jampol LM, Jhaveri CD, Punjabi OS, et al.; DRCR Retina Network. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA. 2020 Dec 15;324(23):2383–2395.
Author contributions
AS designed and drafted the infographic. All contributing authors were involved in providing feedback and finalisation of the work.
Compliance with ethical standards
Conflict of interest
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.